4 - 6 June, 2024
Excel London Platinum Suite Stefan Zielonka, PhDGlobal Head of Antibody Discovery and Protein Engineering at Merck Healthcare KGaASpeaker
Profile
Stefan received his PhD in chemistry from Technische Universität Darmstadt in 2015. At moment he works as Senior Director and Global Head of Antibody Discovery & Protein Engineering at Merck Healthcare KGaA as well as Professor of Biomolecular Immunotherapy at Technische Universität Darmstadt. Stefan holds a habilitation in Biochemistry.
Agenda Sessions
Generation, Engineering and De Novo High-throughput Humanization of VHH-derived Multispecifics for Immune Cell Activation
, 08:20View Session